Hartland & Co »

Denali Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 738k 19.20

More positions owned by Hartland & Co

Vanguard Index Fds Put (VOO)
Paccar (PCAR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Intl (IDEV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Dimensional Etf Trust Intl High Profit (DIHP)
Vanguard Index Fds Total Stk Mkt (VTI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Spdr Index Shs Fds State Street Spd (SPDW)

View all positions for Hartland & Co

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
Temasek Holdings
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
FMR
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Holocene Advisors
Alliancebernstein

View all funds holding Denali Therapeutics